The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Kidney function decline (KFD) in patients undergoing aortic vascular surgical procedures remains a significant global health ...

High-intensity interval training is important, but coming back to your breath can be crucial to helping you train.

At the forefront of innovative, hands-on learning, Georgian is using Meta’s Llama 3 platform, one of the world’s leading open ...

The University of California, the nation's top recipient of federal research funding in higher education, is raising ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

Brighton and Sussex Medical School and Royal Sussex County Hospital researchers have published an analysis of Francis ...

In a viewpoint paper recently published in the journal The Lancet Digital Health, a team led by Stanisa Raspopovic from ...

A scientific team looks at the progress and challenges in the research and development of brain implants. New achievements in the field of this technology are seen as a source of hope for many ...

While attack methods such as phishing and ransomware continue to plague the healthcare industry, artificial intelligence is ...